Terms: = Brain cancer AND AR, P10275, 367, ENSG00000169083, DHTR, SBMA, HUMARA, SMAX1, RP11-383C12_1, TFM, AIS, NR3C4, KD AND Clinical Outcome
662 results:
1. Prognosis versus Actual outcomes in Stereotactic Radiosurgery of brain Metastases: Reliability of Common Prognostic Parameters and Indices.
Mangesius J; Seppi T; Arnold CR; Mangesius S; Kerschbaumer J; Demetz M; Minasch D; Vorbach SM; Sarcletti M; Lukas P; Nevinny-Stickel M; Ganswindt U
Curr Oncol; 2024 Mar; 31(4):1739-1751. PubMed ID: 38668035
[TBL] [Abstract] [Full Text] [Related]
2. Microsurgical removal of supratentorial and cerebellar cavernous malformations: what has changed? A single institution experience.
Meneghelli P; Pasqualin A; Musumeci A; Pinna G; Berti PP; Polizzi GMV; Sinosi FA; Nicolato A; Sala F
J Clin Neurosci; 2024 May; 123():162-170. PubMed ID: 38581776
[TBL] [Abstract] [Full Text] [Related]
3. [
Pruis IJ; Verburg FA; Balvers RK; Harteveld AA; Feelders RA; Vernooij MW; Smits M; Neggers SJCMM; Veldhuijzen van Zanten SEM
J Nucl Med; 2024 May; 65(5):688-692. PubMed ID: 38514085
[TBL] [Abstract] [Full Text] [Related]
4. [Neurosurgical treatment of tumors of the pineal region - literature review and overview of cases at OMIII].
Mezei T; Báskay J; Pollner P; Kovács V; Markia B; Nagy G; Bajcsay A; Sipos L
Magy Onkol; 2024 Mar; 68(1):27-35. PubMed ID: 38484373
[TBL] [Abstract] [Full Text] [Related]
5. Effect of continuous hypertonic saline infusion on clinical outcomes in patients with traumatic brain injury.
Peng C; Chi L; Chen M; Peng L; Yang F; Shao L; Bo L; Jin Z
Neurosurg Rev; 2024 Feb; 47(1):78. PubMed ID: 38340147
[TBL] [Abstract] [Full Text] [Related]
6. Survival and neurological outcomes following management of intramedullary spinal metastasis patients: a case series with comprehensive review of the literature.
Kritikos M; Vivanco-Suarez J; Teferi N; Lee S; Kato K; Eschbacher KL; Bathla G; Buatti JM; Hitchon PW
Neurosurg Rev; 2024 Feb; 47(1):75. PubMed ID: 38319484
[TBL] [Abstract] [Full Text] [Related]
7. GammaTile
Yekula A; Gessler DJ; Ferreira C; Shah R; Reynolds M; Dusenbery K; Chen CC
J Neurooncol; 2024 Feb; 166(3):441-450. PubMed ID: 38281303
[TBL] [Abstract] [Full Text] [Related]
8. National multicentered retrospective review of clinical and intraoperative factors associated with the development of cerebellar mutism after pediatric posterior fossa tumor resection.
Kameda-Smith MM; Ragulojan M; Elliott C; Bliss L; Moore H; Sader N; Alsuwaihel M; Tso MK; Dakson A; Ajani O; Yarascavitch B; Fleming A; Mehta V; Aminnejad M; Farrokhyar F; Singh SK;
Childs Nerv Syst; 2024 May; 40(5):1339-1347. PubMed ID: 38279985
[TBL] [Abstract] [Full Text] [Related]
9. Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC.
Liu JS; Cai YX; He YZ; Xu J; Tian SF; Li ZQ
BMC Cancer; 2024 Jan; 24(1):123. PubMed ID: 38267913
[TBL] [Abstract] [Full Text] [Related]
10. The role of GammaTile in the treatment of brain tumors: a technical and clinical overview.
Garcia MA; Turner A; Brachman DG
J Neurooncol; 2024 Jan; 166(2):203-212. PubMed ID: 38261141
[TBL] [Abstract] [Full Text] [Related]
11. The Application of Sodium Fluorescein in Resection of Medulloblastoma Under YELLOW 560 Filter: Feasibility and Preliminary Results of a Monocentric Cohort and Systematic Review.
Falco J; Broggi M; Rubiu E; Schiariti M; Restelli F; Mazzapicchi E; La Corte E; Ferroli P; Acerbi F
World Neurosurg; 2024 Mar; 183():e386-e394. PubMed ID: 38154682
[TBL] [Abstract] [Full Text] [Related]
12. clinical features and outcomes of advanced HER2+ esophageal/GEJ cancer with brain metastasis.
Liang K; Feliciano JL; Marrone KA; Murray JC; Hann CL; Anagnostou V; Tackett SA; Shin EJ; Hales RK; Voong KR; Battafarano RJ; Yang SC; Broderick SR; Ha JS; Forde PM; Brahmer JR; Lam VK
ESMO Open; 2024 Jan; 9(1):102199. PubMed ID: 38071928
[TBL] [Abstract] [Full Text] [Related]
13. PATIENT-RELATED FACTORS AND clinical MANAGEMENT outcomeS OF RETINOBLASTOMA IN CALABAR, NIGERIA.
Nkanga ED; Nlemadim AC; Arazi M; Nkanga DG; Duke RE; Fabian ID; Nkanga ED; Odey FA; Meremikwu MM
West Afr J Med; 2023 Dec; 40(12 Suppl 1):S36-S37. PubMed ID: 38070170
[TBL] [Abstract] [Full Text] [Related]
14. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
15. Autoantibodies against the chemokine receptor 3 predict cardiovascular risk.
Müller FS; Aherrahrou Z; Grasshoff H; Heidorn MW; Humrich JY; Johanson L; Aherrahrou R; Reinberger T; Schulz A; Ten Cate V; Robles AP; Koeck T; Rapp S; Lange T; Brachaczek L; Luebber F; Erdmann J; Heidecke H; Schulze-Forster K; Dechend R; Lackner KJ; Pfeiffer N; Ghaemi Kerahrodi J; Tüscher O; Schwarting A; Strauch K; Münzel T; Prochaska JH; Riemekasten G; Wild PS
Eur Heart J; 2023 Dec; 44(47):4935-4949. PubMed ID: 37941454
[TBL] [Abstract] [Full Text] [Related]
16. Caveolin-1 mediates the utilization of extracellular proteins for survival in refractory gastric cancer.
Hwang N; Yoon BK; Chun KH; Kim H; Lee Y; Kim JW; Jeon H; Kim TH; Kim MY; Fang S; Cheong JH; Kim JW
Exp Mol Med; 2023 Nov; 55(11):2461-2472. PubMed ID: 37919422
[TBL] [Abstract] [Full Text] [Related]
17. Subarachnoid hemorrhage due to pituitary adenoma apoplexy-case report and review of the literature.
Yildiz Y; Lauber A; Char NV; Bozinov O; Neidert MC; Hostettler IC
Neurol Sci; 2024 Mar; 45(3):997-1005. PubMed ID: 37872321
[TBL] [Abstract] [Full Text] [Related]
18. clinical outcomes of
Hansen KH; Johansen JS; Urbanska EM; Meldgaard P; Hjorth-Hansen P; Kristiansen C; Stelmach M; Santoni-Rugiu E; Ulhøi MP; Dydensborg AB; Dünweber C; Andersen JL
Acta Oncol; 2023 Dec; 62(12):1775-1783. PubMed ID: 37815923
[TBL] [Abstract] [Full Text] [Related]
19. Molecular Features of Resected Melanoma brain Metastases, clinical outcomes, and Responses to Immunotherapy.
Vasudevan HN; Delley C; Chen WC; Mirchia K; Pan S; Shukla P; Aabedi AA; Nguyen MP; Morshed RA; Young JS; Boreta L; Fogh SE; Nakamura JL; Theodosopoulos PV; Phillips J; Hervey-Jumper SL; Daras M; Pike L; Aghi MK; Tsai K; Raleigh DR; Braunstein SE; Abate AR
JAMA Netw Open; 2023 Aug; 6(8):e2329186. PubMed ID: 37589977
[TBL] [Abstract] [Full Text] [Related]
20. Feasibility of comparing medical management and surgery (with neurosurgery or stereotactic radiosurgery) with medical management alone in people with symptomatic brain cavernoma - protocol for the Cavernomas: A Randomised Effectiveness (CARE) pilot trial.
Loan JJM; Bacon A; van Beijnum J; Bhatt P; Bjornson A; Broomes N; Bullen A; Bulters D; Cahill J; Chavredakis E; Colombo F; Danciut M; Digpal R; Edwards RJ; Ferguson L; Forsyth L; Fouyas I; Ganesan V; Grover P; Gurusinghe N; Hall PS; Harkness K; Harris LS; Hayton T; Helmy A; Holsgrove D; Hutchinson PJ; Israni A; Kinsella E; Lewis S; Majeed S; Mallucci C; Mukerji N; Nair R; Neilson AR; Papadopoulos MC; Radatz M; Rossdeutsch A; Raza-Knight S; Stephen J; Stoddart A; Teo M; Turner C; Wade J; Walsh D; White D; White P; Wildman J; Wroe Wright O; Uff C; Ushewokunze S; Vindlacheruvu R; Kitchen N; Al-Shahi Salman R;
BMJ Open; 2023 Aug; 13(8):e075187. PubMed ID: 37558454
[TBL] [Abstract] [Full Text] [Related]
[Next]
